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ABSTRACT 
 
Biosurfactants are amphipathic, surface-active molecules of microbial origin which 
accumulate at interfaces reducing interfacial tension and leading to the formation of 
aggregated micellular structures in solution. Some biosurfactants have been reported to have 
antimicrobial properties, the ability to prevent adhesion and to disrupt biofilm formation. We 
investigated antimicrobial properties and biofilm disruption using sophorolipids at different 
concentrations. Growth of Gram negative Cupriavidus necator ATCC 17699 and Gram 
positive Bacillus subtilis BBK006 were inhibited by sophorolipids at concentrations of 5% 
v/v with a bactericidal effect.  Sophorolipids (5% v/v) were also able to disrupt biofilms 
formed by single and mixed cultures of Bacillus subtilis BBK006 and Staphylococcus aureus 
ATCC 9144 under static and flow conditions, as was observed by scanning electron 
microscopy. The results indicated that sophorolipids may be promising compounds for use in 
biomedical application as adjuvants to other antimicrobial against some pathogens through 
inhibition of growth and/or biofilm disruption.   
 
 
 
 
 
 
 
 
 
 
1. INTRODUCTION 
 
Biosurfactants are amphiphilic compounds produced on living surfaces, mostly on microbial 
cells or excreted extracellular hydrophobic and hydrophilic moieties, with the ability to 
accumulate and partition between fluid phases, thus reducing surface and interfacial tension 
at the surface and interface respectively [1]. Surfactants are widely used in industrial, 
agricultural, food, cosmetic and pharmaceutical applications; however the majority of 
surfactants are derived from petro- or oleochemicals and have the potential to cause 
environmental toxicology problems due to the recalcitrant and persistent nature of these 
substances [2]. 
 
The advantages associated with the use of microbially produced biosurfactants over their 
chemical counterparts include; lower toxicity, higher biodegradability, a wider range of 
effectiveness at different environmental conditions such as pH, temperature and high ionic 
strength, in addition to biocompatibility. These advantages allow applications of 
biosurfactants in cosmetic, pharmaceutical and food additives industries [3].  Biosurfactants 
are classified according to their chemical structure and their microbial origin. The main 
classes of biosurfactants are glycolipids, phospholipids, polymeric compounds and 
lipopeptides. In this work we focus on Sophorolipids (SL), a type of glycolipid. 
Sophorolipids are mainly produced by yeasts such as Candida bombicola and are composed 
of a dimeric sugar linked by a glycosidic bond to a hydroxyl fatty acid [4]. The fatty acid 
structure and carbon chain length may vary depending on the carbon source used to produce a 
given sophorolipid. 
 
Biosurfactants have long been reported as molecules with potential applications in 
environmental and biomedical related areas [5, 6, 7]. There is renewed interest mounting in 
the use of biosurfactants in healthcare associated infections [8] and in particular the rapid 
advances in biofilm inhibition, control or disruption involving their use. Previous studies 
have shown that adsorption of biosurfactants to a solid surface can modify its hydrophobicity, 
affecting the adhesion process and consequently bioﬁlm formation [4]. Most studies 
regarding anti-adhesive properties of biosurfactants were carried out using pure cultures of 
microorganisms and in the absence of culture medium. However it is known that mixed 
cultures are predominantly found in bioﬁlms and that the presence of nutrients can affect the 
adhesion of single and mixed cultures cells [9]. In this work we tested the ability of SL to 
compromise cell membranes and inhibit growth of Gram positive Bacillus subtilis BBK006 
and Gram negative Cupriavidus necator ATCC 17699 bacteria. We also studied the 
disruption of biofilm formation in Bacillus subtilis BBK006, as a single culture as well as in 
mixed cultures of Staphylococcus aureus ATCC 9144 and Bacillus subtilis BBK006, to 
evaluate possible potential use in the health care industry.  
 
 
 
 
 
 
 
 
 
 
2. MATERIALS AND METHODS 
 
2.1 Microorganisms and Media 
Candida bombicola ATCC 22214 was stored in nutrient broth with 20% glycerol at −80°C. 
The standard medium for the production of sophorolipids was glucose/yeast extract/urea 
(GYU) medium (10% w/v glucose, 1% w/v yeast extract, 0.1% w/v urea). The fermentation 
medium contained the same growth medium, with rapeseed oil, as a second carbon source, 
being fed at regular intervals to induce sophorolipid production. For the antimicrobial assays 
Staphylococcus aureus ATCC 9144, Cupriavidus necator ATCC 17699 and Bacillus subtilis 
BBK006 were stored in nutrient broth plus 20% glycerol at −80°C, and used when needed.  
 
2.2 Culture Conditions 
Cupriavidus necator ATCC 17699, Bacillus subtilis BBK006 and Staphylococcus aureus 
ATCC 9144 grown on nutrient agar slants and incubated for 24 h at 30°C were used to obtain 
a bacterial suspension, with the optical density (570 nm) adjusted to give 107 CFU/ml for 
each of the strains used.  
 
2.3 Production of Sophorolipids 
A crude SL (S1) mixture was obtained as the settled product from fed batch cultivation of C. 
bombicola ATCC 22214, operated without the use of antifoam, according to Shah et al [10], 
feeding glucose and rapeseed oil rather than waste frying oil. The dry matter content of the 
crude mixture sophorolipid was adjusted to 45% v/v and contained a mixture of acidic and 
lactonic congeners of sophorolipids (data not shown). Residual fatty acids were less than 1% 
of the total dry sophorolipid mass. As a comparison commercially available SL (S2) were 
used as obtained from Soliance (Reims, France) under the brand name Sopholiance, the main 
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difference between this and the crude S1 mixture being the lack of C18:1 lactonic form and 
the presence of mainly acidic sophorolipids (data not shown). 
 
2.4 Determination of the minimum inhibitory concentration (MIC) of sophorolipids  
One mL of each culture (adjusted to give 107 CFU/ml) was inoculated into a 250 ml 
Erlenmeyer flask containing 50 ml of LB broth, following which a 100 µl sample of each 
diluted culture was dispensed (eight replicates) to fill a 96 well Oxoplate OP96C® for 
antimicrobial assays, where S1 and S2 were applied at 5% v/v.  
OxoPlate OP96C (PreSens, Regensburg, Germany) contains oxygen-sensitive particles PSLi-
Pt-1 (Opto-Sense, Wörth, Germany), which consist of small polystyrene particles. The sensor 
has a thickness of about 10 µm and is fixed at the bottom of each well of a 96-flat bottom-
well plate (Greiner, Frickenhausen, Germany). The oxygen concentration in each well was 
measured for 21 h at 20 min intervals. Fluorescence of each well was measured in dual 
kinetic mode (BMG Labtech GmbH, Germany). Filter pair 1 (544/650nm) detects 
fluorescence of the indicator dye. The second filter pair (544/590 nm) measures fluorescence 
of the reference dye.  
 
All experiments were repeated on independent days. Oxygen concentration as percentage air 
saturation was calculated for each well by using the following equation: 
          
 
           {1} 
 
 
Where R is the ﬂuorescence intensity ratio at the oxygen concentration [O2]. A two-point 
calibration at [O2] 0 and at [O2]=[O2]*, where [O2]* is the saturation concentration, is 
sufﬁcient.  The Intensity ratios IR were calculated for each individual well by dividing the 
intensity of the indicator dye by the intensity of the reference dye. The constant k0 is deﬁned 
as the mean of the IR’s of at least four wells ﬁlled with calibration 0. Analogously, k100 is 
deﬁned as the mean of the IR’s of at least four wells ﬁlled with cal 100. 
 
MIC values were determined by measuring the OD at 570 nm and comparing to those 
cultures where biosurfactant was added. All the biosurfactants were added from time 0 (min) 
to evaluate inhibition in vivo. 
 
 
2.5 Growth and determination of the viability/disruption of biofilms on coverslips. 
Cupriavidus necator ATCC 17699 and Bacillus subtilis BBK006 were grown overnight and 
diluted 100-fold with nutrient broth 50% w/v, following which 2 ml samples were dispensed 
in triplicate to fill a 12 well plate, with biofilms formed on sterile, glass coverslips (18mm x 
18mm) which were put into the 12 well plates (vertically) and were incubated at 30°C for 48 
h. After this period the plates were washed three times and the biosurfactant treatment was 
applied with three replicates, for a period of 30 min (at 200 rpm).  Positive and negative 
controls were added, using MES (2-(N-morpholino) ethanesulfonic acid) and PBS buffer. 
Biofilms were then stained with Syto®9 and the structure was observed with a fluorescence 
microscope at 40X magnification.  
 
 
 
2.6 In vitro Biofilm formation using an eight well chamber 
An overnight culture of Staphylococcus aureus ATCC 9144, Bacillus subtilis BBK006 was 
adjusted to OD490 0.65 and was diluted 1:6 and incubated at 30°C with 5% CO2 for 
approximately 3h in order to reach the mid-log phase. Once the mid-log phase was reached, 
the cells were diluted 1:2500 in fresh nutrient broth and 200 µl were placed in each well and 
incubated for 24h with a change of medium every 12 h to maintain bacterial viability. To 
visualize the biofilms the medium was aspirated and the resident biofilm was washed twice 
with PBS 1X.  The viability of the cells was analysed using 200 µl of BacLight Live/Dead 
stain in each well. The disruption of the biofilms was analysed using SEM, where the cells 
are dehydrated in graded alcohols (50%, 65%, 80%, 95% and 100%) and after the final 
dehydratation step ethanol is replaced with hexamethyldisilazane (HMDS) in ratios of (1:1), 
(1:2), (1:3) and 100%, after which period the samples were left overnight for the solvent to 
evaporate [11] and subsequently the biofilms were observed under SEM.  
  
3. RESULTS  
 
3.1 Effect of MIC of sophorolipids on planktonic cells of Cupriavidus necator ATCC 
17699 and Bacillus subtilis BBK006. 
Surfactants of both biological and chemical origin are usually characterized by the formation 
of aggregated structures such as micelles, their critical micelle concentration (CMC) and their 
foaming and detergent abilities [12, 13, 14]. The Minimum Inhibitory Concentration (MIC) is 
the lowest concentration of a compound that inhibits bacterial growth. Lang and co-workers 
[15] reported some biosurfactant antimicrobial activity towards B. subtilis, S. epidermis and 
P. acnes at low MIC concentrations (<1.6 mM). Figure 1 shows the antimicrobial effect of 
sophorolipids at concentrations higher than 5% (v/v) during the first 3h of growth cells of 
Cupriavidus necator ATCC 17699 and Bacillus subtilis BBK006,  (higher than those 
required to inhibit the grown of other Gram positive and Gram negative bacterial cells 
reported earlier [15,16]). However there is a resistance shown by the cells after 
approximately 3h of time indicating a possible bacteriostatic effect of sophorolipids on 
Cupriavidus necator ATCC 17699 and Bacillus subtilis BBK006, as non-pathogenic models 
of study. 
  
3.2 Biofilm formation by Bacillus subtilis BBK006 on glass coverslips: “static 
conditions” 
The behaviour of planktonic cells and organized structures (biofilms) is different when they 
face stressful environmental conditions. The study model selected for this study was Bacillus 
subtilis BBK006, due to the inability of Cupriavidus necator ATCC 17699 to develop stable 
biofilms.  Bacillus subtilis biofilms were evaluated microscopically after 48h of incubation. 
Fluorescence microscopy examination of cells attached to coverslips and stained with 
Syto®9 showed the presence of individual bacteria, small clusters of cells (microcolonies), 
and extended areas of the glass surface covered with large numbers of microcolonies of 
active cells (Fig 2A). Bacillus subtilis BBK006 was able to form biofilms like those observed 
for other Pseudomonas aeruginosa, Staphylococcus epidermidis strains [17]. The biofilm 
formed was treated with sophorolipid sample S1 (which was selected as no significant 
differences were observed to S2 sample on planktonic cells). In agreement with previous 
studies [18, 19] were are able to confirm here that Bacillus subtilis BBK006 biofilm cells are 
sensitive to some extent to sophorolipids (S1) which was seen by the reduction of number of 
active cells upon exposure and the appearance of some inactive reddish-brown fluorescing 
cells (Fig 2B). The results of the present study indicate that sophorolipids have the potential 
to be used for biofilm disruption and removal. This is in agreement with the data shown by 
Shah et al. [4], who reported sophorolipids having significant antibacterial activities 
especially against Gram positive bacteria. 
  
3.3 Effect of S1 on pre-formed biofilms by Bacillus subtilis BBK006 and mixed cultures 
within the eight well chamber: “flow conditions”. 
In this experiment, sophorolipids at 5% v/v induced disruption on mature maximal biofilms 
of Bacillus subtilis BBK006 and a mixed culture of Bacillus subtilis BBK006 and 
Staphylococcus aureus ATCC 9144. The untreated cells as well as those treated with S1 (5% 
v/v) were examined by SEM to visualize the disruptive effect of sophorolipids on the 
biofilms (Figure 3). The SEM photomicrographs of the control (Figures 3A, 3C and 3E) and 
treated (3B, 3D and 3F) biofilms show the changes in cell morphology. In the control the 
cells form different layers of growth and the extracellular polymeric substance (EPS) are 
visible (Figure 3E). After treatment with sophorolipid only monolayers of cells are observed 
and there is a visible loss of the EPS and a release of the cytoplasmic content (Figure 3F), this 
effect is also supported by results reported by Kim et al [20] and Dengle-Pulate et al [21] 
where Bacillus subtilis cells surfaces (after treatment) were not only distributed in 
monolayers but also disrupted with the outpouring of their cytoplasmic contents, indicating 
that SL causes the release of an intracellular enzyme malate dehydrogenase that interacts with 
SL increasing the permeability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. DISCUSION 
Biosurfactants are amphiphilic compounds produced by microorganisms that reduce surface 
and interfacial tension. They have been recognised for some time in potential applications in 
a wide range of industries including agriculture, food, cosmetic, pharmaceutical and 
petroleum industries [6]. The surface and interfacial tension reducing properties of surfactants 
provide excellent detergency, emulsification, foaming and dispersing traits, making them 
some of the most versatile products in chemical processes [22]. The current hypothesis is that 
surface-active molecules like biosurfactants play a major role in the development and 
maintenance of biofilms, partly through the maintenance of water channels through the 
biofilm which enhance nutrient movement and gaseous exchange which leads to the 
dissociation of parts of the biofilm into planktonic mobile forms [5]. Several strands of 
research have demonstrated that under certain testing conditions, biosurfactants can be more 
effective than many traditional biofilm inhibition and or disruption strategies [23].   
Recently studies [4, 5, 24] reported the use of biosurfactants as antimicrobial molecules, 
however due to the differences between planktonic and biofilm physiologies affected by these 
kind of compounds, this work aimed to evaluating the impact of sophorolipids on cells 
present in both forms/environments, a behavioural variation that so far seems 
inconsequential. Standard bacterial inhibition tests are almost exclusively based on 
planktonic bacterial physiology and not the biofilm physiology, even though these conditions 
are not readily observed in the natural environment. The standard planktonic bacterial 
physiology is typically exemplified by free-living single bacteria with optimal nutrition, gas 
exchange and agitation (typically 250 rpm) [24, 25]. In contrast, the biofilm physiology has 
multicellular differentiation, multicellular communication, internal architecture and 
rudimentary fluid transport systems [26, 27]. Shah et al [4] reported on the antibacterial 
activity of SLs in various carbohydrate-containing media against a selection of Gram-positive 
and Gram-negative bacteria, in our study we selected Cupriavidus necator ATCC 17699 and 
Bacillus subtilis BBK006 as model microorganisms. 
Cupriavidus necator was selected as suitable gram-negative versatile PHB-producing 
bacterium extensively studied and commonly used for its ability to accumulate up to 90% of 
its dry weight as PHB, the first discovered PHA [28, 29]. The extraction of PHAs using 
organic solvents is the most common used technique [30], however there is a need for using 
green and cheap technologies to recover polyhydroxyalkanoates (PHAs) from microbial 
biomass for the development of a reliable and sustainable production chain [31]. The 
importance of the use of sophorolipids is thought to be as a novel molecule proposed to 
extract PHAs from Cupriavidus necator. This however has to be further investigated. 
Bacillus subtilis on the other hand was selected as one of the most studied Gram-positive 
bacteria in terms of the elucidation of the genes, proteins, and molecular mechanisms 
involved in biofilm formation. However we note that among Gram-positive bacteria, the 
molecular mechanisms of biofilm formation appear to be species-specific. Several systems 
are in use to quantify bacterial growth in the presence or absence of these compounds and to 
study planktonic behaviour of diverse populations of cells [5]. Here we used a fluorescence 
assay system, called Oxoplates®, that quantifies the oxygen concentration in the growth 
medium to evaluate the effect of S1 and S2 on planktonic cells of Cupriavidus necator ATCC 
17699 and Bacillus subtilis BBK006. Using this system a minimum number of cells were 
required to consume a threshold amount of oxygen before they were detected in the system. 
All the results presented in Figure 1 are beyond this threshold (high inoculum density), 
consequently consumption of oxygen was detected immediately and the growth medium was 
essentially free of oxygen after 2h, in absence of treatment (Figure 1A).  
In the presence of sophorolipids at 5% v/v we detected similar kinetics of bacterial growth 
inhibition for S1 and S2, where after addition of the treatment the oxygen concentration 
increased (Figure 1B). This increase is attributable to the enhanced diffusion of atmospheric 
oxygen into the wells after cell death, which is an indication that we might be dealing with a 
bactericidal compound. The mechanism for bioactivity of biosurfactants is suggested to be 
associated with their intercalation into target cell membranes, demonstrating in this case that 
sophorolipids are effective against Cupriavidus necator ATCC 17699 and Bacillus subtilis 
BBK006, and that at the concentration tested sophorolipids are comparable to conventional 
antimicrobials used in agriculture and healthcare industry [32], as well as synthetic surfactant 
as SDS for the extraction of PHA [33].   
The deposition of microorganisms on solid surfaces, and subsequent biofilm formation is a 
phenomenon that happens naturally and is part of microorganisms’ strategy to protect 
themselves from external toxic factors [34]. The inability to form biofilms by Cupriavidus 
necator ATCC 17699 led us to focus on the formation of biofilms by Bacillus subtilis 
BBK006 as a model of a gram positive bacteria (most of them can cause various infections 
including hospital-acquired infections), which is best known for its ability to become 
competent and undergo sporulation in response to starvation and high population densities 
[35].  These biofilms are difficult to treat due to their resistance to antibiotics and biocides [4, 
37].  Interestingly the surfactant produced by Streptococcus thermophilus has also been 
shown to be effective industrially for the control of fouling of heat exchanger plates in 
pasteurizers [38].  
In this study biofilm formation of Bacillus subtilis BBK006 was evaluated microscopically 
after 48 h of incubation.  Fluorescence microscopy examination of cells attached to coverslips 
and stained with Syto®9 showed the presence of individual bacteria, small clusters of cells 
(microcolonies), and extended areas of the glass surface covered with large numbers of 
microcolonies of active cells (Fig 2A). Bacillus subtilis BBK006 was able to form biofilms 
like those observed for strains of Pseudomonas aeruginosa and Staphylococcus epidermidis 
[39]. In agreement with previous studies [40, 41] we are able to confirm here that Bacillus 
subtilis BBK006 biofilm cells are sensitive to some extent to sophorolipids as seen by the 
reduction of number of active cells upon exposure and the appearance of some inactive 
reddish-brown fluorescing cells (Fig 2B). These results indicate that sophorolipids have the 
potential to be used for efficient removal of detrimental biofilms. 
It is now generally recognized that biofilms are heterogeneous structures [42] and that the 
appearance of specific biofilm functions such as resistance to antimicrobial agents is 
intimately related to the inherent three dimensional organizations of cells and exopolymeric 
matrix which result from multifactorial processes. Bai and co-workers [43] had previously 
associated biosurfactants with an enhanced transport of bacteria through soil columns, 
achieved through steric hindrance of the contact between bacterium and surface and an 
increase in the negative surface charge density of the soil. Mireles and co-workers [37] 
demonstrated that a range of surfactants (rhamnolipid, surfactin, Tween 80 and sodium 
dodecyl sulphate) brought about dissolution of Salmonella enterica biofilms, which reflects 
the diversity in the nature and recalcitrance of biofilms produced. These observations were 
similar to those reported by Davey and co-workers [44], although different media, strains and 
means for growing biofilms were used, similar conclusions were drawn as in the present 
study. However we note that concentrations evaluated need to be optimized to be considering 
as a focus point for further scale-up of production and future to biotechnological applications.  
The development of a biofilm mainly constitutes a survival strategy for bacteria providing a 
protective environment safe from stresses such as microbicide action and can thus lead to 
significant health-care problems. Using a model of study for biofilm resistance we used a 
mixed culture biofilm of Staphylococcus aureus ATCC 9144 and Bacillus subtilis BBK006 to 
test the effects of sophorolipids. 
Understanding the complex way that bacteria (as single or mixed culture) colonize and build 
specialized structures like biofilms and formulating new strategies to deal with their 
formation or facilitate their disruption through removal or killing are current issues in 
medical and industrial microbiology. One of the possible solutions for this global problem is 
the appropriate use of antimicrobial combinations [45]. In this report, sophorolipids (S1) at 
5% v/v induced disruption on mature maximal biofilms of Bacillus subtilis BBK006 and a 
mixed culture between Bacillus subtilis BBK006 and Staphylococcus aureus ATCC 9144. 
Bacillus subtilis cells treated with sophorolipids were disrupted with the outpouring of their 
cytoplasmic contents, likely due to the release of an intracellular enzyme; malate 
dehydrogenase indicating the interaction of sophorolipids with the cellular membrane and 
increased permeability [21]. This is true for either Gram-positive or mixed cultures, despite 
the fact that most bacterial biofilms display resistance against antimicrobials such as 
antibiotics and various host immune responses [46]. Sophorolipids are biologically produced 
compounds from yeasts strains and are generally regarded as being biocompatible and safe 
for human use while having significant disruption of biofilms produced by different 
microorganisms [47].  
Although the mechanism of action of biosurfactants on biofilm disruption is not well known, 
a generalized activity of altering charge-charge properties is hypothesized [44], which may 
decrease the chances for bacteria to acquire antibiotic resistance due to spontaneous 
mutations. Further studies on the action of different natural sophorolipids, alone or as 
adjuvants in combination with other compounds such as antibiotics or enzymes is of great 
importance. Such combination may play an important role on the stability of the EPS during 
biofilm formation [40, 48] which can lead to new approaches to combat the establishment or 
disrupt biofilms formed by different bacterial species. It is also important to take into account 
that the combinations treatments may behave differently for some species. 
5. CONCLUSIONS 
Sophorolipids were effective as a bactericidal agent regardless of their acid/lactonic 
content, able to induce cell death of planktonic cells of a representative Gram positive and 
Gram negative bacteria comparable to conventional antimicrobials which had 
bacteriostatic effects. Sophorolipids were able as to disrupt biofilms at concentrations 
over than 5% (v/v). The results show that sophorolipids are promising bactericidal 
molecules for biomedical technological applications in industrial systems and need to be 
studied in detail at large scale systems and in conjunction with animal tissue models. 
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